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Effect of K depletion on renal K and Rb excretion: Evidence for
activation of K reabsorption. Prolonged potassium depletion activates
tubular transport mechanisms mediating potassium absorption. To
study ion specificity and factors that modulate the activity of potassium
transport pathways, fractional potassium excretion (FEK) was com-
pared with that of rubidium (PER,,) in control and potassium-depleted
rats subjected to various experimental maneuvers, In control rats FEK
considerably surpassed PER,, (PER/PER,, 1.54 0.08; mean saM),
whereas in potassium-depleted rats PER was significantly lower than
FEE,, (PER/PER,, 0.72 0.05). Preferential retention of potassium
compared to rubidium in potassium-depleted rats was accentuated
(PER/PER,, 0.33 0.01) when residual potassium secretion was inhib-
ited by amiloride and K-H exchange stimulated by increased distal
buffer delivery (metabolic alkalosis). when distal fluid and buffer
delivery were increased in control animals by acetazolamide, PER and
PER,, rose in parallel. In potassium-depleted rats only PER,, but not
PER was enhanced by acetazolamide. These data demonstrate that both
potassium secretory and potassium absorptive transport pathways
prefer potassium to its congener rubidium. Prolonged potassium deple-
tion activates a potassium absorptive mechanism which is stimulated by
increased distal buffer delivery and which transports potassium more
effectively than rubidium.
The precise regulation of potassium transport in distal tubule
segments and the collecting duct system plays a key role in
adjusting renal potassium excretion to potassium intake. In
most physiologic conditions a major fraction of the filtered load
of potassium is reabsorbed along the proximal convoluted
tubule and the loop of Henle [1]. It is along the late parts of the
distal convolution (initial collecting duct) and the cortical col-
lecting duct system that the final adjustments of potassium
excretion are achieved. When potassium intake is normal or
elevated, secretion of potassium along these tubule segments
predominates, the appropriate rates of potassium excretion are
thus assured [I].
During potassium depletion, however, secretion of potassium
along these tubule segments is sharply curtailed and net reab-
sorption occurs [2, 3]. Recent evidence suggests that under this
condition reabsorption of potassium may be accomplished by
an H-K-ATPase located in the apical membrane of a subpop-
ulation of intercalated cells [4—6]. This potassium absorbing
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transport pathway shares many features with the H-K-ATPase
of gastric parietal cells [4—6] and is activated in the cortical and
outer medullary collecting duct by potassium depletion [4].
In studies on renal tubule potassium transport, rubidium has
frequently been used as a marker ion to examine transepithelial
[7—9] and transmembrane potassium movements [10, 11]. In
general, cell transport pathways mediating potassium secretion
prefer potassium to rubidium [9, 10, 12—14]. However, the ion
selectivity of potassium absorbing mechanisms of renal tubule
cells (with regard to potassium and rubidium) is less well
established.
The present investigation was aimed at characterizing in vivo
the ion specificity of the potassium absorbing transport pathway
activated by potassium depletion, and at elaborating some of
the factors which modulate the potassium absorptive mecha-
nism. To this end, we studied the effect on renal potassium and
rubidium excretion of experimental maneuvers designed to
modify distal tubule potassium transport (absorption and secre-
tion of potassium) in control and in potassium-depleted rats.
Methods
Pretreatment and preparation of animals, infusion protocols
Male Wistar rats (SAVO, Kisslegg, Germany) were main-
tained on a standard rat pellet diet (potassium content 230
mmol/kg diet) or on a potassium-deficient diet (C 1037, Al-
tromin, Lage, Germany; potassium content 3 mmol/kg diet) for
10 days, and tap water ad libitum.
Asthesia was induced by the intraperitoneal injection of
Inactin (Byk-Gulden, Konstanz, Germany; 100 to 120 mg/kg
body wt). The animals were placed on a thermo-regulated
operating table (Effenberger, MUnchen, Germany) designed to
keep the animal's temperature at a preset value (37°C). A plastic
tube was inserted into the trachea to insure adequate ventila-
tion. The right jugular vein and the left femoral artery were
cannulated for the infusion of solutions and inhibitors, contin-
uous monitoring of arterial blood pressure, and withdrawal of
blood samples. The left kidney was exposed via a flank incision,
placed in a kidney cup and continuously superfused with warm
paraffin oil (38°C) to prevent heat loss and desiccation. A
catheter was introduced into the ureter and advanced into the
renal pelvis to allow timed urine collections. Glomerular filtra-
tion rate was estimated by the clearance of polyfructosan
(Laevosan, Linz, Austria).
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The experimental protocol included, in all groups of animals,
an initial control period during which polyfructosan (3 g/l00 ml)
in isotonic saline were administered at a rate of 10 mI/hr/kg
body wt followed by the infusion of rubidium, polyfructosan
and, in groups 2, 4, 5, 6, and 7, specific inhibitors as described
below. Urine was collected during five clearance periods, each
lasting 30 minutes, and the control period was terminated after
the first clearance period.
Seven groups of animals were studied:
Group 1. Control diet (N = 5). Following the control period
these animals received an infusion solution of 75 m rubidium
chloride, 75 m sodium chloride and polyfructosan (3 g/l00 ml)
at a rate of 10 mllhr/kg body wt.
Group 2. Control diet, acetazolamide (N = 5). The infusion
protocol of this group of animals was similar to that of group 1. _____________________________________________________
During the last 30 minute period acetazolamide (Sigma, Deisen-
hofen, Germany; 5 mg/hr/kg body wt) was added to the infusion
solution in addition to rubidium chloride, sodium chloride and
polyfructosan.
Group 3. Low K diet (N = 9). The same infusion protocol was
used as in group 1.
Group 4. Low K diet, acetazolamide (N = 5). The infusion
protocol of this group of rats was identical to that of group 2.
Group 5. Low K diet, amiloride (N = 6). After the control
period amiloride (1 mg/hr/kg body wt; Sigma, Deisenhofen,
Germany) was added to the infusion solution containing sodium
chloride, rubidium chloride and polyfructosan. The infusion
rate was maintained at 10 mI/hr/kg body wt.
Group 6. Low K diet, amiloride and alkalosis (N = 5).
Following the control period as in group 1 the infusion solution
(10 mI/hr/kg body wt) contained sodium bicarbonate (75 mM),
rubidium carbonate (Rb2CO3 37.5 mM), polyfructosan and
amiloride (1 mg/hr/kg body wt; Sigma).
Group 7. Low K diet, Sch 28080 (N 4). Following the
control period as in group 1 the infusion solution (10 ml/hr/kg
body wt) contained 75 m rubidium chloride, 75 mM sodium
chloride, polyfructosan (3 g/l00 ml) and the H-K-ATPase
inhibitor Sch 28080 (dose: 2.5 mg/hr/kg body wt).
Blood was taken at the midpoint of each clearance period for
the determination of plasma sodium, potassium, rubidium and
polyfructosan concentrations. To minimize possible redistribu-
tion of rubidium between red cells and plasma the separation of
cells and plasma was carried out immediately following the
withdrawal of blood. To avoid volume contraction and hemodi-
lution, the red blood cells obtained after centrifugation of the
blood samples were resuspended in an albumin solution (4 g
albumin dissolved in 100 ml isotonic saline) and reinfused.
Chemical analyses
Sodium and potassium concentrations in plasma and urine
were measured by flame photometry (IL, Lexington, Massa-
chusetts, USA), rubidium concentrations by atomic absorption
spectrophotometry (Pye Unicam, Cambridge, UK). Polyfruc-
tosan was determined by the anthrone method of Fuhr, Kacz-
marczyk and Kruttgen [151. Polyfructosan clearance and the
fractional excretion of potassium, rubidium and sodium were
calculated using the standard formulae.
Table 1. Effect of rubidium infusion on plasma values and






Plasma potassium concentration 4.07 0.10 3.90 0.13
mmol/liter
Plasma rubidium concentration 0.26 0.01
mmol/liter
Plasma sodium concentration mmol/ 141.1 0.9 141.9 0.9
liter
Urine flow rate ,td/min/100 g body wt 1.80 0.33 10.84 2.21a
Glomerular filtration rate ml/minIIOO 0.50 0.04 0.45 0.03
g body wt
Fractional potassium excretion % 29.2 2.9 66.0 39a
Fractional rubidium excretion % 43.2 3.1
Fractional sodium excretion % 0.22 0.07 1.09 0.24a
Values are means SEM; number of animals = 5
a Significantly different from corresponding value of the control
period
Presentation of data and statistical analysis
The data are presented as means SEM with (ZI) indicating
the number of measurements. Comparisons between two sets of
data were performed by t-test for paired or unpaired data as
appropriate. Differences with P values less than 0.05 were
regarded as significant. If more than two groups had to be
compared, analysis of variance was carried out in a first step.
Differences between individual groups were then tested in a
second step by t-test using appropriately adjusted significance
levels [161.
Results
The effects of intravenous rubidium administration on plasma
electrolytes and renal function in control animals (group 1) are
summarized in Table 1. Infusion of rubidium caused urine flow,
and fractional excretions of potassium and sodium to rise
without significantly affecting glomerular filtration rate. The
sharp increment in fractional potassium excretion induced by
rubidium is also apparent from inspection of Figure 1 which
depicts the time course of the fractional excretions of potassium
(FEK) and rubidium (FERb). The stimulation of renal potassium
excretion by the infusion of the rubidium-containing solution is
noteworthy, because plasma potassium concentration tended to
be lowered by the infusion of rubidium chloride (Table 1).
Confirming previous observations in rats on a control diet FEK
is consistently higher than FERb. This is reflected by a FEK/
FERb ratio significantly exceeding unity (1.54 0.08 during the
final clearance period).
When potassium excretion in control animals was stimulated
by increasing distal delivery of sodium and fluid by acetazola-
mide, fractional excretions of both potassium and rubidium
were increased in parallel (Table 2). The marked rise in FEK by
acetazolamide was associated with a significant fall in plasma
potassium concentration and glomerular filtration rate. At the
same time urine flow and FENa were greatly enhanced by this
maneuver.
To examine whether the discrimination by tubular transport
mechanisms between potassium and rubidium was altered
during chronic alterations in body potassium homeostasis, the








Table 3. Effect of rubidium infusion on plasma values and







Plasma potassium concentration 3.06 0.10 3.84 o.lo
mmollliter
Plasma rubidium concentration 0.29 0.01
mmol/liter
Plasma sodium concentration mmol/ 142.5 1.0 144.0 0.7
liter
Urine flow rate ,JImin/100 g body wi 2.35 0.61 3.73 0.62
Glomerular filtration rate ml/min/100 0.44 0.02 0.38 o.o3
g body WI
Fractional potassium excretion % 1.58 0.14 4.58 1.32a
Fractional rubidium excretion % 5.40 1.41
Fractional sodium excretion % 0.07 0.02 0.30 0.11Control Experimental period
I I I I Values are means SEM; number of animals = 90 30 60 90 120 150 a Significantly different from corresponding value
period
Time, minutes
Fig. 1. Fractional excretion of potassium (open squares) and rubidium(filled squares) in animals on a control diet. During the experimental
period rubidium chloride was administered i.v. *significantly different
from corresponding fractional potassium excretion (by paired I-test; P
<0.05). The data are given as means SEM; N = 5.
Table 2. Effect of acetazolamide on plasma values and parameters of








Plasma potassium 3.94 0.09 3.76 0.08 3.58 0.06l
concentration mmol/
liter
Plasma rubidium 0.20 0.01 0.24 0.01"
concentration mmol/
liter
Plasma sodium 141.6 0.5 141.7 0.8 141.9 0.4
concentration mmol/
liter
Urine flow rate .d/min/ 2.06 0.62 11.77 2.70a 21.57 2,87a,b
100 g body WI
Glomerular filtration rate 0.57 0.02 0.50 O,OP 0.45 0.0l"
ml/minIlOO g body WI
Fractional potassium 29.2 3.8 62.2 3.8a 91.8 20a,b
excretion %
Fractional rubidium 39.5 1.4 66.4 4.0"
excretion %
Fractional sodium 0.31 0.12 0.76 0.24 4.42 045a,b
excretion %
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Time, minutes
Fig. 2. Fractional excretion of potassium (open squares) and rubidium(filled squares) in animals on a low-K diet. During the experimental
period rubidium chloride was administered i.v. *significantly different
from corresponding fractional potassium excretion (by paired f-test; P
<0.05). The data are given as means SEM; N = 9.
excretion of both potassium and rubidium increased gradually
(Fig. 2). It should be noted that infusion of rubidium induced a
modest increase in the plasma potassium concentration in the
low-K animals, whereas such an effect was absent in animals on
a control diet (compare Tables 1 and 3). We have previously
shown that infusion of rubidium is a powerful stimulus for
potassium excretion, thus accounting for a tendency for the
plasma potassium concentration to decline in control animals
[12]. This effect is absent in low-K animals because of the
sharply attenuated potassium secretion. Accordingly the re-
lease of potassium ions by rubidium from tissues such as muscle
[17] and kidney [12] leads to an increase of plasma potassium
concentration.
Importantly, fractional excretion of potassium was less than
that of rubidium; accordingly, the relation between FEK and
Values are means SEM; number of animals = 5; acetazolamide was
given during the final experimental period.
a Significantly different from corresponding value of the control
periodb Significantly different from corresponding value of the third exper-
imental period
renal excretion of potassium and rubidium was studied in
potassium-depleted animals (group 3). In this group FEK was
initially sharply reduced to values less than 2% (control period;
Table 3, Fig. 2). When these rats on a low-K diet were infused
with a solution containing 75 mrs rubidium chloride, plasma
potassium concentration rose significantly (Table 3) and the










Plasma potassium 3.02 0.08 3.55 0.06 3.79 010b
concentration mmol/
liter
Plasma rubidium 0.22 0.01 0.27 0.O2'
concentration mmol/
liter
Plasma sodium 143.7 1.2 145.9 1.6 145.1 0.8
concentration mmol/
liter
Urine flow rate .tl/min/ 2.53 0.24 7.20 1.69 11.46 2.62a
100 g body Wi
Glomerular filtration rate 0.45 0.02 0.44 0.02 0.44 0.02
ml/min/l00 g body wt
Fractional potassium 1.43 0.11 6.83 1.78 6.86 l.42a
excretion %
Fractional rubidium 8.14 1.65 14.3 3 24"
excretion %
Fractional sodium 0.10 0.02 0.71 0.15 3.38 076a,b
excretion %
FERb was reversed (0.72 0.05 during final clearance period)
compared with control animals. After 120 minutes of rubidium
infusion glomerular filtration rate was significantly lower than
during control period (Table 3).
As shown in Table 2, in animals on a control diet acetazola-
mide caused a rise in the fractional excretion of both potassium
and rubidium (see above). In potassium-depleted rats, however,
the acetazolamide-induced increase in distal flow rate and distal
delivery of sodium and buffer were associated with increased
FERb while FEK remained unaffected (third vs. fourth clear-
ance period of group 4 rats; Table 4, Fig. 3).
To test whether the rise in FEK and FERb observed during
rubidium infusion in potassium-depleted animals (Fig. 2) was
due to stimulation of tubular potassium secretion, amiloride, an
agent known to impair distal potassium secretion, was admin-
istered together with rubidium (group 5). In this group the
initially very low FEK during the control period was even
further reduced by amiloride during the experimental period
(Fig. 4), although plasma potassium concentration rose signifi-
cantly (control period vs. final experimental period; Table 5).
Urine flow and FENa tended to be higher than in potassium-
depleted rats given rubidium without amiloride (group 4).
Amiloride caused urine potassium concentration (0.99 0.19
mmollliter during fourth experimental period) to fall to values
well below plasma potassium concentrations. These results
suggest that even after prolonged potassium deprivation potas-
sium secretion, albeit reduced, is still operative in amiloride-
sensitive tubule segments.
Since K-H exchange has been shown to be activated in distal
tubule segments by potassium deprivation [4], we examined
whether increased distal delivery of buffer alters the pattern of
0J I _____
Control pj
0 30 60 90 120 150
Time, minutes
Fig. 3. Effect of acetazolamide on fractional excretion of potassium
(open squares) and rubidium (filled squares) in animals on a low-K diet.
During the experimental period rubidium chloride was administered i.v.
*signilicantly different from corresponding fractional potassium excre-
tion (by paired t-test; P < 0.05). The data are given as means SEM; N
= 5.
0- Amitoride
Control p Experimental period
0 30 60 90 120 150
Time, minutes
Fig. 4. Effect of amiloride on fractional excretion of potassium (open
squares) and rubidium (filled squares) in animals on a low-K diet.
During the experimental period rubidium chloride was administered i.v.
*significantly different from corresponding fractional potassium excre-
tion (by paired t-test; P < 0.05). The data are given as means SEM; N
= 6.
renal potassium and rubidium excretion in potassium-depleted
animals. When amiloride, given to inhibit distal secretion of
potassium, was combined with metabolic alkalosis, to increase
distal buffer delivery, potassium excretion rates were curtailed
while plasma potassium concentration and FENa were signifi-
cantly increased (Table 6). Under this condition the preferential
Table 4. Effect of acetazolamide on plasma values and parameters of








Values are means 5EM; number of animals = 5; acetazolamide was
given during the final experimental period.
Significantly different from corresponding value of the control
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Table 5. Effect of amiloride on plasma values and parameters of







Plasma potassium concentration 2.62 0,06 3.52 0. l6
mmol/liter
Plasma rubidium concentration 0.24 0.02
mmol/liter
Plasma sodium concentration mmoll 142.6 0.8 142.6 0.6
liter
Urine flow rate pJImin/100 g body wi 2.04 0.26 7.63 1.3&
Glomerular filtration rate mi/mm/bC 0.46 0.02 0.36 0.04
g body wt
Fractional potassium excretion % 2.08 0.34 0.56 0. 12
Fractional rubidium excretion % 1.39 0.30




Values are means SEM; number of animals = 6
a Significantly different from corresponding value of the control
period
Table 6. Effect of amiloride in combination with alkalosis on plasma























Plasma potassium concentration 2.74 0.09 3.40 0. ISa
mmol/liter
Plasma rubidium concentration 0.27 0.01
mmol/iiter
Plasma sodium concentration mmol/ 140.6 0.5 139.9 0.9
liter
Urine flow rate pd/mm/bOO g body wt 3.20 0.40 6.54 0.78a
Glomerular ifitration rate mi/mm/bOO 0.40 0.02 0.40 0.02
g body wt
Fractional potassium excretion % 2.45 0.39 0.52 0.09a
Fractional rubidium excretion % 1.60 0.28
Fractional sodium excretion % 0.21 0.03 1.91 0.19a
Fig. 5. Comparison of fractional potassium excretion (FE) with that
of rubidium (FERb) in different experimental conditions. Values above
unity indicate preferential excretion of potassium, values below unity
preferential excretion of rubidium.
passive and active mechanisms is more effective than that of
rubidium [9, 12—14, 18—19].
Figure 6 summarizes relevant potassium and sodium trans-
port pathways in initial and cortical collecting duct cells. The
Figure also includes possible sites where potassium secretion
and reabsorption may be modulated. Potassium secretion in
principal cells is depicted to occur by active basolateral uptake
via Na-K-ATPase, followed by passive diffusion from cell to
lumen via potassium-selective channels [1]. Amiloride inhibits
potassium secretion by blocking apical sodium channels and
hyperpolarizing the apical cell membrane [1, 3, 20]. Potassium
reabsorption occurs by apical active potassium-hydrogen ex-
change in a subpopulation of intercalated cells [1]. The baso-
lateral exit pathway of potassium in intercalated cells is un-
known. Under controls conditions, Muto, Giebisch and Sansom
found that the basolateral membrane in which impalements
were done was largely permeable to chloride but not to potas-
sium [211. However, studies in potassium-deficient animals in
which potassium reabsorption is stimulated have not yet been
carried out. It is possible that potassium exit from cells to
peritubular fluid in these cells involves translocation via newly
inserted potassium channels or via K-Cl cotransport.
In rats on a control or high potassium diet, potassium
secretion along the initial and cortical collecting duct is the
predominant mode of transepithelial potassium transport [1]. In
states of potassium deprivation, potassium secretion is sharply
depressed and potassium reabsorption stimulated [1]. Several
studies have demonstrated that both basolateral Na-K-ATPase
and apical potassium channels discriminate between rubidium
and potassium: active potassium uptake via Na-K-ATPase and
passive fluxes across the apical potassium channels exceed
those of rubidium [9, 13, 141. We now present evidence that the
potassium reabsorptive pathways also have a higher affinity for
potassium over rubidium ions.
Our observation that fractional potassium excretion in rats on
a control diet surpasses fractional rubidium excretion confirms
Values are means sEM; number of animals = 5
a Significantly different from corresponding value of the control
period
renal retention of potassium compared to rubidium was accen-
tuated so that the FEK/FERb ratio reached a value as low as 0.33
0.01 (Fig. 5).
On the other hand, the administration of an inhibitor of
H-K-ATPase would be expected to reverse the tendency for
preferential potassium reabsorption. This was observed when
the FEK/FERb ratio was evaluated in rats on a low-K diet (group
7). Following infusion of Sch 28080 fractional potassium excre-
tion increased from 1.58 0.13% in the control period to 3.83
0.51% (final experimental period). At the same time the
FEK/FERb ratio rose to a mean value of 0.85 0.04.
Discussion
Rubidium has been used frequently as a marker ion for the
study of potassium transport in the kidney [10, 18, 19] and
single tubule segments [7—9]. Both clearance studies [18, 19] as
well as investigations of potassium transport in specific tubule
segments [9] and tubule cells [10, 12—14, 19] show that secretory
potassium transport pathways discriminate between potassium
and rubidium ions. In general, secretion of potassium by
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potassium retention may involve both apical and basolateral
components. With respect to apical transport mechanisms,
Basolateral potassium retention over that of rubidium is consistent with
more effective transport of potassium ions by the apical K-H
exchange. Supportive evidence for involvement of apical mech-
anisms is our observation that increased buffer delivery to distal
tubule segments accentuated preferential potassium retention
over that of rubidium (Fig. 5). We also note that the opposite
effect, an increase of relative potassium excretion, follows
administration of Sch 28080, a known specific inhibitor of K-H
exchange (Fig. 5).
A number of studies have convincingly demonstrated the
presence of potassium-activated ATPase along the connecting
tubule and the collecting duct system [4—6]. The activity of this
potassium-conserving transport pathway is stimulated by po-
tassium depletion. However, the observation that the low
fractional excretion rates of potassium in potassium-depleted
rats fall further after amiloride (Fig. 4, Table 5) suggests that
even after prolonged potassium deprivation, secretion of potas-
sium along amiloride-sensitive tubule segments still contributes
to urinary potassium excretion.
If, in analogy to potassium secretory pathways, potassium
absorptive mechanisms also prefer potassium over rubidium,
stimulation of distal potassium absorption should enhance renal
retention of potassium more effectively than that of rubidium.
K This was indeed observed: first, potassium ions were more
effectively conserved when potassium-retrieving transport
mechanisms were stimulated by potassium deprivation. Sec-
ond, when distal fluid and buffer delivery were increased in
control animals by acetazolamide, potassium and rubidium
excretion were both stimulated in parallel. In potassium-de-
pleted animals, however, acetazolamide greatly activated ru-
bidium excretion, whereas that of potassium remained un-
changed (Fig. 3). We propose that during acetazolamide
administration, despite the fact that potassium secretion was
stimulated significantly as evidenced by increased rubidium
excretion, the additional moiety of potassium was effectively
retrieved by potassium reabsorption which had been activated
both by potassium deprivation and increased buffer delivery.
The greater efficiency of the potassium-reabsorbing mecha-
nisms explains that rubidium, having entered the tubule via
potassium secretory pathways, escaped reabsorption and was
thus more efficiently excreted than potassium.
Preference of potassium over rubidium by potassium absorb-
ing mechanisms also explains our observation that the lowest
ratio of fractional excretion rates of rubidium/potassium (0.33
0.01) was attained in potassium-depleted rats when potassium
secretion was further inhibited by amiloride and potassium-
hydrogen exchange stimulated by increased distal buffer deliv-
ery (group 6; Table 6).
Concerning the mechanism(s) of discrimination of distal
cation-reabsorptive mechanisms, it is of interest that the po-
tency of potassium to activate gastric H-K-ATPase in an apical
membrane vesicle preparation is about threefold higher than
that of rubidium [221. In a study of passive potassium and
rubidium movement in the isolated frog skin, it was further
shown that both apical and basolateral membranes discriminate
sharply between potassium and rubidium, such that potassium
fluxes exceeded those of rubidium by a factor of two [23].









Fig. 6. Cell schemes of potassium-secreting and potassium-absorbing
tubule cells in the initial and cortical collecting tubule. A. Transport
mechanisms of principal cells. Potassium ions are normally secreted by
active uptake across the basolateral cell membrane and passive diffu-
sion from cell to tubular fluid. This process is inhibited by dietary
potassium deprivation and amiloride. Potassium secretion is stimulated
by alkalosis and administration of carbonic anhydrase inhibitors [11. B.
Transport mechanisms of a-intercalated cells. Potassium absorption is
depicted to occur by ATP-dependent K-H exchange in the apical
membrane. The mechanism(s) by which potassium ions leave the cell
are presently unknown. Potassium reabsorption is stimulated by potas-
sium deprivation [1]. Hydrogen secretion is achieved by K-H exchange
and by electrogenic hydrogen secretion. Both processes are activated
by high luminal delivery rates of bicarbonate and other buffers.
previous observations. Since such preferential potassium ex-
cretion is completely abolished by amiloride [12], an agent
known to suppress potassium secretion along the initial and
cortical collecting duct, we conclude that potassium secretory
pathways along these tubule segments discriminate between
rubidium and potassium in favor of the latter. Similar conclu-
sions were reached in patch-clamp, elecrophysiological and
tracer flux studies in cortical collecting ducts [9, 13, 14].
The present experiments extend observations on distal tubule
potassium transport pathways by demonstrating that potassium
depletion stimulates the more effective conservation of potas-
sium over rubidium. The mechanisms of such preferential
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harvested from potassium-deprived animals, however, have
demonstrated similar stimulation by potassium and rubidium of
H-K-ATPase-dependent cation fluxes [24]. If these findings can
be extrapolated to the collecting duct system in vivo, the
possibility must be considered that rubidium movement across
the basolateral membrane of tubule cells may be slower than
that of potassium, and contribute to its less effective transcel-
lular reabsorption. Electrophysiological studies on single prin-
cipal cells support the notion of a lower basolateral rubidium
permeability compared to that of potassium [91. Such studies
have not yet been carried out in intercalated cells, and accord-
ingly we cannot be certain whether the site of discrimination
between the two cations resides within the basolateral cell
membrane. However, our observation that a subpopulation of
intercalated cells has exceedingly high rubidium contents fol-
lowing rubidium infusions [12] suggests that rubidium, once
taken up into the cell by pump mechanisms, remains trapped
because of low basolateral potassium permeability. Taken
together these considerations support the view that transepithe-
hal reabsorptive pathways prefer rubidium over potassium.
We conclude from our studies that distal tubule transport
pathways discriminate between potassium and rubidium in
conditions in which potassium absorption is stimulated and
potassium secretion inhibited. The observation that potassium
is retained more effectively reflects the ion specificity of the
transport pathways that are involved in potassium reabsorp-
tion.
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